Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke

The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.

Saved in:
Bibliographic Details
Main Authors EYDING DIRK, SOHNGEN WOLFGANG, AL-RAWI YASIR ALAA S, SOHNGEN MARIOLA
Format Patent
LanguageEnglish
Published 06.03.2008
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention refers to the use of non-neurotoxic plasminogen activating factors, e.g., from Desmodus rotundus (DSPA) or genetically modified plasminogen activating factors, for example of human origin, for the therapeutic treatment of stroke in mammals.
Bibliography:Application Number: US20070878686